Glioblastoma treatment using perphenazine to block the subventricular zone’s tumor trophic functions R. E. KastB. M. EllingsonM.-E. Halatsch Topic Review 17 November 2013 Pages: 207 - 212
Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma Denise FeierabendJan WalterChristian Ewald Laboratory Investigation 27 October 2013 Pages: 213 - 220
18beta-Glycyrrhetinic acid induces apoptosis in pituitary adenoma cells via ROS/MAPKs-mediated pathway Di WangHei-Kiu WongZhang-Jin Zhang Laboratory Investigation 27 October 2013 Pages: 221 - 230
Efficacy and selectivity of nilotinib on NF1-associated tumors in vitro Wei JiangClaudia SchnabelLan Kluwe Laboratory Investigation 31 October 2013 Pages: 231 - 236
Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system Rebekka UnlandKornelius KerlMichael C. Frühwald Laboratory Investigation 22 November 2013 Pages: 237 - 249
The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma Qi YueXin ZhangYing Mao Laboratory Investigation Open access 26 November 2013 Pages: 251 - 259
Retrospective evaluation of the outcomes of children with diffuse intrinsic pontine glioma treated with radiochemotherapy and valproic acid in a single center Francisco Helder Cavalcante FelixOrlandira Leite de AraujoJuvenia Bezerra Fontenele Clinical Study 30 November 2013 Pages: 261 - 266
Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas Rakesh Kumar GuptaMehar C. SharmaChitra Sarkar Clinical Study 01 November 2013 Pages: 267 - 274
Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers Giuseppe MinnitiAntonella ArcellaRiccardo Maurizi Enrici Clinical Study 26 October 2013 Pages: 275 - 282
Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire Eefje M. SizooLinda DirvenMartin J. B. Taphoorn Clinical Study 29 October 2013 Pages: 283 - 290
Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme Eun Young KimRaphael YechieliSamuel Ryu Clinical Study 31 October 2013 Pages: 291 - 297
Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study Takeo UzukaKenichiro AsanoTohoku Brain Tumor Study Group Clinical Study 31 October 2013 Pages: 299 - 306
Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 Rosa NguyenKimberly JettVictor-Felix Mautner Clinical Study 29 October 2013 Pages: 307 - 313
A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients An-an YinSang CaiXiang Zhang Clinical Study 01 November 2013 Pages: 315 - 324
Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes Rajiv ManglaDaniel Thomas GinatSven Ekholm Clinical Study 01 November 2013 Pages: 325 - 331
Quality of life research in neuro-oncology: a quantitative comparison Elizabeth KleinDavid AltshulerNicholas Szerlip Clinical Study 05 November 2013 Pages: 333 - 340
Vision specific quality of life in children with optic pathway gliomas Robert A. AveryKristina K. Hardy Clinical Study 07 November 2013 Pages: 341 - 347
Incidence and prognostic value of multiple gene promoter methylations in gliomas Longzhou ZhangMaode WangJun Mo Clinical Study 06 November 2013 Pages: 349 - 356
Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma Daniel E. SprattMichael FolkertYoshiya Yamada Clinical Study 05 November 2013 Pages: 357 - 363
A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme Michelle Alonso-BasantaPenny FangJay F. Dorsey Clinical Study 06 November 2013 Pages: 365 - 372
Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI Robert J. HarrisSusan Y. BookheimerBenjamin M. Ellingson Clinical Study 14 November 2013 Pages: 373 - 379
Skull base meningiomas: neurological outcome after microsurgical resection Judith ScheitzachKarl-Michael SchebeschMartin A. Proescholdt Clinical Study 21 November 2013 Pages: 381 - 386
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study F. E. FroklageL. J. OosterbaanT. J. Postma Clinical Study 22 November 2013 Pages: 387 - 394
Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution Haihui JiangXiaohui RenSong Lin Clinical Study Open access 22 November 2013 Pages: 395 - 404
Molecular analysis of diffuse intrinsic brainstem gliomas in adults German Reyes-BoteroMarine GiryMarc Sanson Clinical Study 17 November 2013 Pages: 405 - 411
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry Oscar GallegoM. CuatrecasasA. Barnadas Clinical Study Open access 19 December 2013 Pages: 413 - 419
Misinterpretation of statistical results and recurrent intracranial hemangiopericytoma Da LiJun-Ting Zhang Letter to the Editor 02 November 2013 Pages: 421 - 422
